MAO-B Polymorphism Associated with Progression in a Chinese Parkinson’s Disease Cohort but Not in the PPMI Cohort

Table 5

Summary of polymorphisms correlated with PD progression among diverse populations.

Correlation setting	Cohort	Polymorphism
Mild setting	PPMI Caucasians	SYT4.RIT2, PTHLH, PRKN, MAPT, LOC105377329, SNCA haplotype, PARK16 haplotype, CCDC62
	All Asian	SYT4.RIT2, RAB29, PRKN, PLA2G6, NUCKS1, MAO-B, LRRK2 haplotype, LRRK2, HLA-DRA, COMT, SNCA haplotype, PARK16 haplotype
	PPMI Asian	SYT4.RIT2, RAB29, PLA2G6, PARK7, MAPT, MAO-B, LRRK2 haplotype, LRRK2, LOC105377329, GPNMB, COMT, BST1
	TW	SYT4.RIT2, PRKN, PLA2G6, MAO-B, LRRK2 haplotype, LRRK2 R1628P.H, LRRK2 G2385 R, COMT
Strict setting	PPMI Caucasians	SYT4.RIT2, SNCA haplotype
	All Asian	PRKN, NUCKS1, MAO-B, SNCA haplotype, PARK16 haplotype
	TW	MAO-B